As Women's History Month wraps up, it's time to reflect on the enabling diversity and inclusion in the workplace as a driver of innovation. Photo via Getty Images

Pop quiz: What's the best way to introduce and nurture a culture of innovation in your organization?

  1. Give all employees a VR headset
  2. Mandate every team leader offer one new idea per quarter
  3. Add the word "innovate" to the organization's mission statement
  4. Actively recruit, hire and support a more diverse workforce

If you didn't answer D, you have some research to do. A trove of recent research shows an undeniable link between workforce diversity and innovation, not to mention better overall results. From McKinsey to the Boston Consulting Group to HBR the data keeps coming.

For instance, Deloitte found organizations with more inclusive cultures are both significantly more innovative and twice as likely to meet or exceed financial targets than their counterparts. My own company, Sodexo, commissioned a study that found gender-balanced teams contribute to better outcomes across the board, including innovation.

Beyond the hard evidence, pure common sense tells us when we open our doors to people with different perspectives and life experiences, we also welcome new ideas. Diverse teams encourage diverse thinking, new solutions and agile implementation. There's a reason that Great Place to Work calls diverse and inclusive teams "the engines of innovation."

At the same time, innovation has become essential in our current economic climate. If this past year has taught us anything, it's that we need to be nimble and ready to think differently at a moment's notice.

As we close out another Women's History Month, we are rounding out a year that has been a collective setback for women in the workplace, in particular. Millions of women have left the labor market during the global pandemic and it's unclear how many will return and what professional repercussions they will face.

This comes as our industry was already woefully lacking gender parity. According to a 2019 Catalyst study, there were fewer women in oil and gas than almost any other major industry. The group found women accounted for only 22 percent of employees, 17 percent of senior level roles and one percent of top leadership.

In other words, the pandemic has given us even more work to do — both in recruiting women and a more diverse employee base in general. We need to do so if we are to transform into the future-oriented industry our customers need us to be.

The news is not all doom and gloom, however. An eye-opening McKinsey report about our industry, "Oil and gas after COVID-19" argues that the global pandemic "will be a catalytic moment and accelerate permanent shifts in the industry's ecosystem, with new future opportunities." The authors lay out several potential avenues for successful organizations, including the ability to "create the organization of the future," by recruiting a new blend of talent that will bring innovative ideas.

This is a watershed moment to rethink how we recruit and hire. We can look more broadly at what we look for and from which fields we recruit. We can consider how different ideas and perspectives can help us forge paths toward our future.

We have the data to fuel the changes we need. We also have the data to offer us the cautionary tale of not changing. As the McKinsey report put it: "The opportunity to lead has never been better—separation between market leaders and laggards will be increasingly sharp."

------

Stephanie Hertzog is the CEO of Houston-based Sodexo Energy & Resources North America.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.